Progress: Procedure completed
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | ENVI | BORZAN Biljana ( S&D), HÄUSLING Martin ( Greens/EFA), HAZEKAMP Anja ( The Left) |
Lead committee dossier:
Legal Basis:
R, u, l, e, s, , o, f, , P, r, o, c, e, d, u, r, e, , E, P, , 1, 1, 5, -, p, 2, -, 3
Legal Basis:
R, u, l, e, s, , o, f, , P, r, o, c, e, d, u, r, e, , E, P, , 1, 1, 5, -, p, 2, -, 3Subjects
Events
The European Parliament adopted by 474 votes to 166, with 17 abstentions, a resolution objecting to the Commission Implementing Decision (EU) 2024/1826 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP23211 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council.
On 11 December 2019, Pioneer Overseas Corporation, based in Belgium, submitted, on behalf of Pioneer Hi-Bred International, Inc., based in the United States, an application to the national competent authority of the Netherlands for the placing on the market of foods, food ingredients and feed containing, consisting of or produced from genetically modified maize DP23211, consisting of the GM maize for uses other than food and feed, with the exception of cultivation.
The GM maize contains genes conferring resistance to glufosinate and produces insecticidal proteins.
Parliament highlighted the lack of assessment of complementary herbicides . It recalled in this regard that a number of studies show that herbicide-tolerant GM crops result in a higher use of complementary herbicides, in large part because of the emergence of herbicide-tolerant weeds.
Glufosinate is classified as toxic to reproduction 1B. The approval of glufosinate for use in the Union expired on 31 July 2018.
Member States submitted many critical comments to EFSA, including that the monitoring plan concerned does not ensure that relevant information for the monitoring of the product is gathered and therefore cannot be considered adequate, as well as that the insecticidal protein produced by the plant has not been adequately assessed.
Parliament stressed the need to ensure a global level playing field given the challenge of diverging standards of the Union and its trading partners, and to respect the EU's international obligations .
According to Members, authorising the import for food or feed uses of any GM plant which has been made tolerant to herbicides is incoherent with the Union’s international commitments under, inter alia, the United Nations Convention on Biological Diversity and the United Nations Sustainable Development Goals, including the recently adopted Kunming-Montreal Framework, which includes a global target to reduce the risk of pesticides by at least 50 % by 2030. It is also important to reduce the dependency on imported feed.
On a procedural note, Parliament recalled that it adopted 38 resolutions objecting to the placing GMOs on the market. Despite its own acknowledgement of the democratic shortcomings, the lack of support from Member States and the objections of Parliament, the Commission continues to authorise GMOs.
On the basis of these considerations, Parliament considered that the Implementing Decision is not consistent with Union law , which is to provide the basis for ensuring a high level of protection of human life and health, animal health and welfare, and environmental and consumer interests, in relation to GM food and feed, while ensuring the effective functioning of the internal market.
Therefore, Parliament called on the Commission to:
- repeal Implementing Decision (EU) 2024/1826 ;
- ensure convergence of standards between the Union and its partners in free trade agreement negotiations, in order to meet Union safety standards;
- not authorise herbicide-tolerant GM crops, due to the associated increased use of complementary herbicides and therefore the increased risks to biodiversity, food safety and workers’ health;
- deliver, as matter of urgency, on its commitment to come forward with a proposal to ensure that hazardous chemicals banned in the Union are not produced for export;
- take into account the Union’s obligations under international agreements , such as the Paris Climate Agreement, the United Nations Convention on Biological Diversity and the United Nations Sustainable Development Goals. The draft implementing acts should be accompanied by an explanatory memorandum explaining how they uphold the principle of ‘do no harm’.
Text adopted by Parliament, single reading
Documents
- Decision by Parliament: T10-0043/2024
- Motion for a resolution: B10-0150/2024
- Motion for a resolution: B10-0150/2024
Activities
- Biljana BORZAN
Institutional Motions (1)
- Martin HÄUSLING
Institutional Motions (1)
- Anja HAZEKAMP
Institutional Motions (1)
History
(these mark the time of scraping, not the official date of the change)
committees/0 |
|
committees/0 |
|
docs/0/body |
Old
EPNew
European Parliament |
events |
|
forecasts |
|
procedure/dossier_of_the_committee |
Old
New
ENVI/10/01011 |
procedure/legal_basis |
Old
New
Rules of Procedure EP 115-p2-3 |
procedure/stage_reached |
Old
Awaiting plenary debate/voteNew
Procedure completed |
procedure/title |
Old
Objection pursuant to Rule 115(2) and (3) D096838 - authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP-023211-2, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the CouncilNew
Resolution on Commission Implementing Decision (EU) 2024/1826 authorising the placing on the market of products containing, consisting of or produced from genetically modified maize DP23211 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council |